METHYLVINYL CYCLOSILOXANE
General Information
Mainterm | METHYLVINYL CYCLOSILOXANE |
CAS Reg.No.(or other ID) | 68082-23-5 |
Regnum |
175.320 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 77507 |
IUPAC Name | 2,4,6-tris(ethenyl)-2,4,6-trimethyl-1,3,5,2,4,6-trioxatrisilinane |
InChI | InChI=1S/C9H18O3Si3/c1-7-13(4)10-14(5,8-2)12-15(6,9-3)11-13/h7-9H,1-3H2,4-6H3 |
InChI Key | BVTLTBONLZSBJC-UHFFFAOYSA-N |
Canonical SMILES | C[Si]1(O[Si](O[Si](O1)(C)C=C)(C)C=C)C=C |
Molecular Formula | C9H18O3Si3 |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 258.495 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 3 |
Complexity | 243.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B w M A w A A A A A A A A A A A A A A A A A A A A A A A A k A A A A A A A A A A A A A A A A G B A A A E A A A A C A I A B C A A A A A A G A A A A C A A A A A A A A A A A I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 27.7 |
Monoisotopic Mass | 258.056 |
Exact Mass | 258.056 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 15 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9553 |
Human Intestinal Absorption | HIA+ | 0.8840 |
Caco-2 Permeability | Caco2+ | 0.6121 |
P-glycoprotein Substrate | Non-substrate | 0.7444 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7977 |
Non-inhibitor | 0.9834 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.9229 |
Distribution | ||
Subcellular localization | Mitochondria | 0.5596 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8454 |
CYP450 2D6 Substrate | Non-substrate | 0.8364 |
CYP450 3A4 Substrate | Non-substrate | 0.6422 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6961 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8740 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9307 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7578 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7527 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8915 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9394 |
Non-inhibitor | 0.9823 | |
AMES Toxicity | Non AMES toxic | 0.7683 |
Carcinogens | Non-carcinogens | 0.6419 |
Fish Toxicity | Low FHMT | 0.8285 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9391 |
Honey Bee Toxicity | High HBT | 0.7599 |
Biodegradation | Not ready biodegradable | 0.9928 |
Acute Oral Toxicity | III | 0.5183 |
Carcinogenicity (Three-class) | Non-required | 0.5520 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -2.0950 | LogS |
Caco-2 Permeability | 1.4694 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.5862 | LD50, mol/kg |
Fish Toxicity | 1.7729 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.1950 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organometallic compounds |
Class | Organometalloid compounds |
Subclass | Organosilicon compounds |
Intermediate Tree Nodes | Not available |
Direct Parent | Organoheterosilanes |
Alternative Parents | |
Molecular Framework | Aliphatic heteromonocyclic compounds |
Substituents | Organoheterosilane - Organic metalloid salt - Organic oxygen compound - Hydrocarbon derivative - Organic salt - Aliphatic heteromonocyclic compound |
Description | This compound belongs to the class of organic compounds known as organoheterosilanes. These are organosilicon compounds where the tetravalent silicon atom is linked to one or more heteroatoms. |
From ClassyFire